PTC Therapeutics PTCT Intangible Purchases
Intangible Purchases at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's intangible purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's intangible purchases?
- PTC Therapeutics (PTCT) reported intangible purchases of $156K in Q1 2026.
- How has PTC Therapeutics's intangible purchases changed year-over-year?
- PTC Therapeutics's intangible purchases decreased by 80.7% year-over-year, from $808K to $156K.
- What is the long-term trend for PTC Therapeutics's intangible purchases?
- Over 4 years (2021 to 2025), PTC Therapeutics's intangible purchases has grown at a 50.3% compound annual growth rate (CAGR), from $57.12M to $291.15M.
- What does intangible purchases mean?
- Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.